HOME >> MEDICINE >> NEWS
First study of Viagra(R) in black men demonstrates treatment as effective, well tolerated

ORLANDO, May 25, 2002 - In the first study to evaluate the efficacy and safety of Viagra (sildenafil citrate) in black men with erectile dysfunction (ED), approximately eight out of 10 patients reported improvement in their erectile function and ability to have sexual intercourse after taking Viagra for six weeks, according to data scheduled to be presented at the annual meeting of the American Urological Association.

In this study of 246 black men, patients were randomly assigned to receive Viagra or placebo for six weeks, at which point they were given the choice to switch to the alternate treatment for another six weeks. At week six, a significantly larger percentage of Viagra-treated patients reported improved erections and improved ability to have sexual intercourse (79 percent and 81 percent) compared with placebo-treated patients (38 percent and 36 percent). Additionally, patient satisfaction was greater in the Viagra-treated group than in the placebo group.

Data also presented at the meeting by Culley Carson, M.D. of the University of North Carolina, Chapel Hill, examined the prevalence of ED in a nationally representative population sample of white, black and Hispanic American men, as defined by US census criteria, aged 40 and above. The study found that ED was a common problem among black men, with 24 percent of men reported to be only "sometimes" or "never" able to get and keep a satisfactory erection, compared to 22 percent of white and 20 percent of Hispanic men respectively.

Cardiovascular disease, high blood pressure and diabetes are all highly prevalent among black men. Because ED is often associated with such conditions, it is especially important to screen and treat black men who are experiencing erection problems," said Jean Bonhomme, M.D., Founder, National Black Men's Health Network. "We have now confirmed that Viagra is an effective and well tolerated treatment option for these men."

The prevalence study,
'"/>

Contact: Geoffrey Cook, Pfizer
212-733-5244
Porter Novelli
25-May-2002


Page: 1 2

Related medicine news :

1. First head-to-head study to compare lidoderm patch and Celebrex in treating pain
2. First UK cases of previously rare disease reported in gay men
3. First mouse model for multiple system atrophy points to new treatment targets for brain diseases
4. Mayo Clinic researchers create obedient virus; First step to use measles virus against cancer
5. First US kidney cancer vaccine trial underway at Columbia
6. First new treatment for alcoholism in ten years, now available Campral(R) (acamprosate calcium)
7. First blood test to diagnose paralyzing, blinding disease
8. First US SARS vaccine trial opens at NIH
9. First-ever safety study of medical cannabis use in Canada launched
10. First solid evidence that the study of music promotes intellectual development
11. First medical test on CD gets good results

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... 2017 , ... The American Board of Family Medicine's (ABFM) Board of Directors ... Officer, succeeding Dr. James C. Puffer upon his retirement. Dr. Newton will serve in ... retirement at the end of 2018. Upon assuming the role of President and CEO ...
(Date:10/13/2017)... , ... October 13, 2017 ... ... of Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ... on guideline updates for the primary prevention of cardiovascular diseases during the ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Many families ... However, many long-term care insurance companies have a waiver for care if the client ... elimination period, when the family pays for care, is often waived, so the benefits ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Global Healthcare Management’s ... Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s ... The fun run is geared towards children of all ages; it is a ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in agile ... a contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise ... use of Agile methodologies in a consistent and high value manner across CMS ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... LAWRENCE, Mass. , Oct. 4, 2017 /PRNewswire/ ... developer of single-use, self-contained, illuminating medical devices, today ... National Health Surveillance Agency (or Agência Nacional ... ®. The first single-use, cordless surgical retractor with ... ONETRAC provides optimal access, illumination and exposure of ...
(Date:10/2/2017)... Oct. 2, 2017  Eli Lilly and Company (NYSE: ... for the third quarter of 2017 on Tuesday, October ... on that day with the investment community and media ... The conference call will begin at 9 a.m. Eastern ... a live webcast of the conference call through a ...
(Date:10/2/2017)... Halo Labs announces the European launch of their new low volume, ... 2017 in Cambridge, U.K on October 4th. ... samples with unprecedented speed and sensitivity while using far less sample ... ... system ...
Breaking Medicine Technology:
Cached News: